News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
How targeting a rare blood cancer complication, or bacteria in colorectal cancer bolster immunotherapy outcomes? – CRI
CRI/LinkedIn
Oct 11, 2024, 14:30

How targeting a rare blood cancer complication, or bacteria in colorectal cancer bolster immunotherapy outcomes? – CRI

Cancer Research Institute (CRI) shared on LinkedIn:

“How could targeting a rare blood cancer complication, or bacteria in colorectal cancer bolster immunotherapy outcomes?

CRI Clinical Innovator Dr. Julio Delgado of Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and CRI Postdoctoral Fellow Dr. Jorge Luis Galeano Niño of The University of Texas at El Paso share their insights in our newest blog, during National Hispanic Heritage Month.”

More posts featuring Cancer Research Institute on oncodaily.com

cancer Cancer research Cancer Research Institute (CRI) Jorge Luis Galeano Niño Julio Delgado OncoDaily Oncology
Special Coverage
Blog
Dec 30, 2024, 19:52
CelloType: A New Machine Learning Tool for Analyzing Cancer Cells and Tissues
Blog
Dec 30, 2024, 19:26
“QI Scholar Nursing Presentations Part 2” from the SIOP Nursing Network
Science
Dec 30, 2024, 13:52
Nico Gagelmann: Selected clinical studies 2024 in hematology
Insight
Dec 30, 2024, 13:43
Roupen Odabashian: When it comes to real-life cases, physicians still outperform AI
Blog
Dec 30, 2024, 13:42
Shaban Juma: The key to being one step ahead in the fight against cancer
Positive
Dec 30, 2024, 13:42
Improving the lives of children with cancer everywhere - St. Jude Children's Research Hospital
Blog
Dec 30, 2024, 13:37
Matthew Pech: The failure of ex vivo gene therapy for sickle cell and the role of the TPP in the drug development process
Insight
Dec 30, 2024, 13:35
James Crowley: Elevated expression of CCR7 is generally indicative of poor prognosis in cancers
Insight
Dec 30, 2024, 13:30
Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer
Blog
Dec 30, 2024, 13:25
Sanjay Popat: Wouldn’t it be great if FDA Oncology approvals were mutually approvable by MHRA?
Insight
Dec 30, 2024, 13:23
Satya Prakash Yadav: 2024 blockbuster Menin inhibitor for infant ALL
Insight
Dec 30, 2024, 13:10
Promising response to lurbinectedin in NUT carcinoma by M.V. Sánchez Becerra et al. - Vivek Subbiah